Healthy volunteers Hypertension
Conditions
Interventions
Subjects receive 6 tablets/day (2 tablets/time) containing a total of 180 mg of Salacia oblonga extract for 3 weeks.
Subjects receive 6 tablets/day (2 tablets/time) containing a total of 540 mg of Sal
Sponsors
Hiroshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Diagnosed as high-normal blood pressure or grade I hypertension through health checks twice or more in three years 2) With habit of eating 3 meals a day
Exclusion criteria
Exclusion criteria: 1) Taking antihypertensive 2) Taking medicines for chronic disease other than antihypertensive 3) Taking functional food that may affect the trial 4) Participation in any clinical trial within 90 days of the commencement of the trial 5) In pregnancy or nursing a child 6) Judged as ineligible by clinical investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-week change in home blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-week change in ankle-brachial index (ABI) and office blood pressure | — |
Countries
Japan
Contacts
Public ContactFumiko Higashikawa
Hiroshima University, Institute of Biomedical & Health Sciences Project Research Center for Clinical Trial and Preventive Medicine
Outcome results
None listed